Related Experiment Video

Updated: Aug 20, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Apoptotic mechanisms of gallium nitrate: basic and clinical investigations

Christopher R Chitambar1

  • 1Division of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. chitambr@mcw.edu

Oncology (Williston Park, N.Y.)
|January 18, 2005
PubMed

Insights

Gallium nitrate effectively inhibits lymphoma cell growth and shows promising antitumor activity in patients. This novel chemotherapy agent targets cancer cells via transferrin receptors, offering a potentially less toxic treatment option.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Gallium nitrate demonstrates inhibitory effects on lymphoma cell lines in vitro.
  • Its antitumor activity in lymphoma patients is recognized, though mechanisms require further elucidation.
  • Gallium shares chemical properties with iron, influencing its cellular interactions.

Purpose of the Study:

  • To investigate the cytotoxic mechanisms of gallium nitrate.
  • To evaluate its therapeutic potential in lymphoma treatment.
  • To assess its safety profile, particularly regarding myelosuppression.

Main Methods:

  • Studied gallium nitrate's effects on lymphoma cell lines in vitro.
  • Investigated gallium's cellular uptake via transferrin receptors.
  • Analyzed intracellular processes affected by gallium, including iron transport and ribonucleotide reductase.
  • Reviewed data from Phase II clinical trials in relapsed/refractory lymphoma patients.

Main Results:

  • Gallium nitrate targets cells expressing high levels of transferrin receptors, common in lymphoma cells.
  • Cellular uptake disrupts iron homeostasis and inhibits ribonucleotide reductase, leading to proliferation inhibition.
  • Gallium induces apoptosis through caspase activation.
  • Phase II trials show gallium nitrate's antitumor activity is comparable or superior to existing agents.
  • Gallium nitrate is not myelosuppressive, allowing use in patients with neutropenia or thrombocytopenia.

Conclusions:

  • Gallium nitrate exhibits significant antitumor activity against lymphoma through specific intracellular mechanisms.
  • Its unique non-myelosuppressive profile makes it a valuable therapeutic option for lymphoma patients, including those with compromised blood counts.
  • Ongoing trials are further evaluating its efficacy in relapsed non-Hodgkin's lymphoma.

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue11:22

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...